Inovio Pharmaceuticals, Inc. financial data

Symbol
INO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
6769 Mesa Ridge Rd., San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INOVIO BIOMEDICAL CORP (to 5/11/2010), GENETRONICS BIOMEDICAL CORP (to 4/1/2005), GENETRONICS BIOMEDICAL LTD (to 8/3/2001)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 409 % +11%
Debt-to-equity 40.4 % -9.51%
Return On Assets -77.6 % -42.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26M shares -90.3%
Common Stock, Shares, Outstanding 26M shares -90.3%
Entity Public Float 120M USD -71.9%
Common Stock, Value, Issued 26K USD -90.3%
Weighted Average Number of Shares Outstanding, Basic 27.2M shares +23.5%
Weighted Average Number of Shares Outstanding, Diluted 27.2M shares +23.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 592K USD -93.8%
Research and Development Expense 76.8M USD -40.6%
General and Administrative Expense 40.9M USD -23%
Operating Income (Loss) -128M USD +26.1%
Net Income (Loss) Attributable to Parent -122M USD +27.8%
Earnings Per Share, Basic -5.09 USD/shares +69.6%
Earnings Per Share, Diluted -5.09 USD/shares +69.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34.4M USD -34.8%
Cash, Cash Equivalents, and Short-term Investments 110M USD -43.4%
Accounts Receivable, after Allowance for Credit Loss, Current 1.77M USD
Assets, Current 118M USD -42.2%
Property, Plant and Equipment, Net 4.51M USD -28.4%
Operating Lease, Right-of-Use Asset 8.82M USD -7.05%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 586K USD -12.1%
Assets 134M USD -42.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 26.4M USD -49.2%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 10.7M USD -8.92%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 37.1M USD -41.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -690K USD +0.25%
Retained Earnings (Accumulated Deficit) -1.69B USD -7.78%
Stockholders' Equity Attributable to Parent 96.7M USD -42.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 222M USD -44.4%
Liabilities and Equity 134M USD -42.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.8M USD +21.6%
Net Cash Provided by (Used in) Financing Activities -11.4M USD -2576%
Net Cash Provided by (Used in) Investing Activities 45.4M USD +139%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 26M shares -90.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.29M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 34.4M USD -34.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 533K USD +0.06%
Deferred Tax Assets, Valuation Allowance 327M USD +9.48%
Deferred Tax Assets, Gross 329M USD +9.3%
Operating Lease, Liability 13M USD -7.64%
Depreciation 424K USD -40%
Payments to Acquire Property, Plant, and Equipment 35.6K USD -88%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32.3M USD +9.52%
Lessee, Operating Lease, Liability, to be Paid 16.1M USD -11%
Property, Plant and Equipment, Gross 25.8M USD -11.9%
Operating Lease, Liability, Current 2.32M USD -1.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.56M USD +16.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.47M USD +13.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.14M USD -22.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.96M USD -5.86%
Deferred Tax Assets, Operating Loss Carryforwards 236M USD +10.7%
Preferred Stock, Shares Issued 9 shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 22.1M USD +4.61%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.31M USD -8.55%
Additional Paid in Capital 1.78B USD +2.84%
Preferred Stock, Shares Outstanding 9 shares 0%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 1.99M USD -13.9%
Interest Expense 1.09M USD -13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%